Concourse Financial Group Securities, Inc. Inmune Bio, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$4.86 - $9.86 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$7.15 - $11.84 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$10.53 - $14.01 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$6.6 - $11.52 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$6.61 - $10.9 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$6.61 - $10.9 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$6.5 - $10.09 $0 - $0
Q1 2023 May 15, 2023	BUY	$6.01 - $10.18 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$6.13 - $7.96 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$6.04 - $10.44 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.48 - $8.97 $0 - $0
Q1 2022 May 09, 2022	BUY	$6.42 - $11.39 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$9.97 - $20.38 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$14.13 - $27.85 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$9.29 - $19.33 $0 - $0
Q1 2021 May 13, 2021	BUY	$11.61 - $26.85 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$7.51 - $17.22 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.92 - $15.75 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.1 - $6.09 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.21 - $6.15 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.56 - $6.1 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$5.32 - $10.0 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$7.45 - $11.0 $0 - $0
Q1 2019 May 15, 2019	BUY	$7.08 - $8.2 $0 - $0

Others Institutions Holding INMB

# of Institutions

Shares Held

5.92M

Call Options Held

243K

Put Options Held

46.4K

Black Rock Inc. New York, NY

813K
Shares

$3.65 Million
0.0% of portfolio
Praetorian Pr LLC Rincon, PR

781K
Shares

$3.51 Million
1.64% of portfolio
Vanguard Group Inc Valley Forge, PA

721K
Shares

$3.24 Million
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

596K
Shares

$2.68 Million
45.87% of portfolio
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL

369K
Shares

$1.66 Million
0.0% of portfolio

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $80.6M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account